Panduit Launces Innovative Solar Drain Clip to Boost Solar Panel Efficiency Across Asia Pacific

Revolutionary drainage solution addresses critical maintenance challenges in the region's diverse climate conditions
SINGAPORE, June 11, 2025 /PRNewswire/ -- Panduit, a global leader in electrical and network infrastructure solutions, today announced the launch of its Solar Drain Clip in the Asia Pacific market. This innovative product addresses one of the most significant challenges facing solar installations across the region's diverse climates: water accumulation and its negative impact on solar panel efficiency and longevity.
Experience the full interactive Multichannel News Release here: https://www.multivu.com/panduit/9337151-en-panduit-launces-innovative-solar-drain-clip
The Asia Pacific region has seen unprecedented growth in solar energy adoption, with installations expected to increase by 40% over the next five years. However, the region's varied climate conditions—from monsoon seasons to high humidity environments—present unique challenges for maintaining optimal solar panel performance.
"Water accumulation on solar panels is particularly problematic across APAC where intense rainfall and humidity can accelerate dirt buildup and algae growth," said Gavin Lee, Business Development Director for Asia Pacific. "Our Solar Drain Clip provides a simple yet effective solution that can significantly reduce maintenance costs while maximizing energy output—addressing a critical need for solar installations throughout the region."
Optimized Drainage for Maximum Efficiency
The Solar Drain Clip improves drainage by effectively directing water off panel surfaces, minimizing residue buildup that can cause shading and reduced power output. By maintaining cleaner panel surfaces, the clip helps sustain consistent energy generation in all weather conditions, a particular advantage during monsoon seasons experienced across many parts of APAC.
Engineered for Asia Pacific's Demanding Environments
With an estimated service life exceeding 20 years*, the Solar Drain Clip is specifically designed to withstand the region's harshest environmental conditions, from extreme heat and humidity to heavy seasonal rainfall. This durability stands in harsh contrast to lower-grade alternatives that typically require replacement within 1-2 years.
"For large-scale solar installations across Asia Pacific, the reduction in maintenance frequency translates to significant operational cost savings," added Lee. "This makes our Solar Drain Clip particularly valuable for utility-scale solar farms and commercial installations throughout the region."
Key Features and Benefits:
Availability
The Panduit Solar Drain Clip is now available through authorized Panduit distributors across the APAC region. For more information, visit https://www.panduit.com/asean/en/products/featured-products/panduit-solar-drain-clip.html or contact your local Panduit representative.
About Panduit
Panduit is a leading global manufacturer of high-quality electrical and network infrastructure and connectivity solutions. Operating from our headquarters in Tinley Park, Ill., USA, and across 112 worldwide locations, we drive innovation through strategic R&D investments and breakthrough product development while providing seamless global support and service. Since 1955, our commitment to our customers and partners has remained constant. And together, with them, we create exceptional solutions that support their businesses in a way that's good for them and good for the world. Panduit is making the connections that matter. For more information, visit www.panduit.com.

Try Our AI Features

Explore what Daily8 AI can do for you:

Learn with AIFact CheckingText to SpeechAI Summary

Related Articles

Korea Herald

15 minutes ago

• Korea Herald

[Editorial] Beyond Kospi rally

South Korea's stock surge signals renewed optimism, but fundamentals remain weak On Friday, South Korea's stock market crossed a threshold it had not seen in more than three years. The main bourse, Kospi, a barometer of investor sentiment as much as economic health, closed at 3,021.84, reclaiming the 3,000 mark for the first time since December 2021. For investors long resigned to an index drifting between 2,200 and 2,800, this was no ordinary trading session. Once the psychological barrier gave way mid-morning, market euphoria carried the index higher, ending a symbolic drought that had outlasted two governments and multiple global disruptions. The rally came less than three weeks after President Lee Jae Myung's electoral victory and inauguration. It would be tempting and politically expedient to interpret the surge as a resounding vote of confidence. But the reality is more complicated and more fragile. The Kospi's rise has been powered not by earnings but by expectations. Investors are responding to the administration's vow to eliminate the 'Korea discount,' the chronic undervaluation of domestic equities rooted in weak governance, geopolitical tensions and low shareholder returns. President Lee's pledge to push the index to 5,000 may sound ambitious or even fantastical. Still, it has clearly altered the mood. A proposed revision to the Commercial Act, along with the unveiling of a 30.5 trillion won ($22.2 billion) supplementary budget last week, has further buoyed sentiment. Global conditions have provided additional lift. A weaker dollar and growing liquidity have drawn foreign investors back into the South Korean market after nearly a year of net selling. More than 5 trillion won in foreign inflows were recorded in June alone. Hopes for interest rate cuts and a temporary easing of tariff tensions have added to the tailwinds. These, however, remain volatile forces that could quickly reverse. More importantly, a fundamental tension persists. Market performance has diverged sharply from the real economy. The Bank of Korea projects gross domestic product growth will slow to just 0.8 percent this year. Corporate earnings, especially among export-heavy firms with exposure to the US, are under pressure. Forecasts for the auto sector have already declined by nearly 3 trillion won since the start of the year. Consumer demand remains weak. The government's decision to pursue a second supplementary budget is less a sign of strength than a measure of urgency. This disconnect should caution against premature celebration. The Kospi's recovery is encouraging, but it rests on a fragile foundation. The structural issues that have long suppressed valuations — a static industrial base, slow-moving reform and recurring external shocks — remain unresolved. Geopolitical risks with potential implications for South Korean assets loom large, as the US launched strikes on three key nuclear facilities in Iran early Sunday, inserting itself into the escalating conflict between Israel and Iran. The initial impact on markets will emerge Monday, amid concerns that US President Donald Trump's high-stakes gamble may undercut the recent momentum in Korean equities. To sustain a higher valuation, South Korea will need something more durable than momentum. A more predictable regulatory environment, deeper capital markets and genuine earnings growth are all essential. Industrial renewal is also critical. Over the past two decades, the country's leading exports have barely changed. Unlike in the US, where market leadership shifts alongside technological innovation, South Korea's corporate hierarchy has remained largely fixed. This is the harder path — and the more essential one. Legal and fiscal adjustments can spark brief rallies, but lasting gains depend on deeper institutional reform and renewed competitiveness. South Korea must not mistake a breakout for a breakthrough. The Kospi's return to 3,000 is not a verdict, but an invitation to build a more resilient economy, a more credible market and a more compelling growth story. The market has priced in hope; fulfilling it will take more than promises.

Korea Herald

11 hours ago

• Korea Herald

Lee discusses stimulus, diplomacy with bipartisan delegation

Lee hosts ruling and opposition party leadership for lunch, just 18 days into presidency President Lee Jae Myung held a lunch meeting with a bipartisan delegation Sunday at his official residence in Hannam-dong, Yongsan-gu, Seoul, to discuss the government's recent stimulus proposal and his visit to Canada to attend the G7 summit last week. There, Lee stressed a need to narrow down differences between rival parties. "Many world leaders (I met during the G7 summit) had a significant amount of interest in South Korea's present and future, so I thought we could conciliate with each other over the external issues," Lee said. "I thought we should review the economic situation of South Korea and the issues of national security and diplomacy that lay the foundation for South Korea's economy. Especially, we should work on the extra budget bill, and it is natural to have different opinions," he continued. Bowls of colorful noodles were served at lunch, according to the presidential office. The meeting marked the start of "candid conversation" between the president and leaders of rival parties, Woo Sang-ho, senior presidential secretary for political affairs, said in a briefing on Sunday Present at the meeting were Rep. Kim Byung-kee, floor leader of the ruling Democratic Party of Korea; Rep. Kim Yong-tae, interim leader of the main opposition People Power Party and People Power Party Whip Rep. Song Eon-seog. The ruling party chair position has yet to be filled. The primary focus of the meeting was the 30.5 trillion won ($22.2 billion) supplementary budget that is set to be tabled at the National Assembly on Monday. Among the extra budget is a 15.2 trillion-won stimulus plan, largely designed to shore up consumption by doling out 13 trillion won worth of cash-equivalent coupons to all South Korean citizens. Each individual will receive coupons worth at least 150,000 won. Additionally, 5 trillion won was allocated in the supplementary budget for small businesses and economically marginalized groups. The plan includes a 1.4 trillion won scheme to write off debts of small business owners -- up to 50 million won per individual -- that have been overdue for seven years or more. The liberal government's budget proposal gained Cabinet approval Thursday. At the meeting, People Power Party's interim leader Kim told Lee that he was wary of expansionary fiscal policy because it could lead to inflation. Kim also said Lee's debt write-off plan could prompt people's unwillingness to resolve delinquency. The ruling liberal party has the legislative power to single-handedly pass the budget bill, as it requires at least half of the votes by National Assembly lawmakers present at the session. The parliament is currently led by the ruling Democratic Party, which occupies 167 seats out of the 298. The conservative main opposition People Power Party holds 107 seats. Just before Sunday's lunch meeting, Democratic Party floor spokesperson Rep. Kim Hyun-jung claimed that a plenary session to pass the extra budget bill must take place before July 4, regardless of whether the People Power Party consents. Also during the meeting, Lee shared with the political leaders about his debut on the international stage as a guest at the Group of Seven summit, according to the presidential office. Chief of staff Kang Hoon-sik, on Tuesday, had extended a general invitation to the opposition party leaders while Lee was in Canada for the G7 summit. On Thursday, Lee told Kang that the meeting with bipartisan leadership should take place early, and the date was set for Sunday. This stands in contrast with Lee's conservative predecessor Yoon Suk Yeol, who first met the then-opposition leader Lee about two years into his presidency in April 2024, only after the then-ruling People Power Party suffered a crushing defeat in the general election.

Korea Herald

13 hours ago

• Korea Herald

[Bio USA] SK Biopharmaceuticals CEO highlights resilience, open innovation amid global shifts

Korea Herald correspondent BOSTON — SK Biopharmaceuticals CEO Lee Dong-hoon underscored the company's preparedness for potential US tariff changes and emphasized the critical role of open innovation in shaping the future of global pharmaceuticals. 'We've weathered volatility in our share price over the past year, but the impact of potential price cuts has been minimal,' Lee said Thursday during a press conference on the sidelines of the 2025 Bio USA. 'Our direct-to-market sales model remains fundamentally solid.' He recalled a particularly tense moment earlier this year when shifting US tariff policies posed logistical challenges. In April, the company rushed to transport finished products from Canada into the US before a new tariff deadline. 'When the final truck finally cleared customs, everyone burst into applause,' he recounted. To prevent such risks from recurring, the company now assembles finished products in Canada and ensures shipments cross the border ahead of any policy changes. Looking ahead, SK Biopharmaceuticals is evaluating Puerto Rico as a potential US-based manufacturing site, leveraging its status as a US territory and pharmaceutical hub. 'Canada is cost-effective for now, but we're preparing for every scenario,' Lee said, noting the company's tariff risk is now 'close to zero' for the year. Lee also expressed confidence in the company's long-term growth. 'We've already announced our goal to hit 1 trillion won ($728 million) in sales by 2029, and we're on track,' he said, citing consistent profitability since last year. A cornerstone of SK Biopharmaceuticals' strategy is open innovation. Instead of relying solely on internal research and development, the company is partnering with universities, biotech firms and research institutions. 'Major global pharmaceutical firms are moving away from in-house basic research, and so are we. When you can collaborate and generate results at a fraction of the cost, your possibilities expand," he explained. The CEO emphasized the importance of tapping into underutilized technologies at US universities and biotech startups to diversify the company's pipeline, moving beyond its core focus on epilepsy into areas like oncology. Artificial intelligence is another major focus area. Lee highlighted the company's work on EEG-based seizure prediction models in collaboration with European and South American partners, along with AI algorithm development trials currently underway in Korea. 'AI is no longer optional. It's essential in every part of the business,' he said. One standout partnership is with PhnyX Lab, whose AI-driven automation of clinical documentation significantly reduced paperwork. 'Even our US team, which was initially skeptical, was blown away,' Lee said, calling the shift 'Copernican' in scale for how it will reduce time and cost. The CEO also outlined plans to build a global digital platform for epilepsy patients — a space where patients and physicians can share experiences and insights. 'It's not about selling drugs,' he clarified. 'It's about collecting data to inform AI-powered marketing, drug development and clinical trial design.' The company is looking three to five years ahead, aiming to build an ecosystem where shared data drives innovation across functions. In the US, SK Biopharmaceuticals is intensifying its engagement with health care providers. Lee has personally met with dozens of physicians this year, aiming for 100 meetings, to gather insights that will shape lifecycle strategies such as patent extensions, expanded indications and new formulations like IV delivery. Meanwhile, SK Biopharmaceuticals has invested in targeted TV and YouTube campaigns for its flagship epilepsy drug, Xcopri (cenobamate). Its 'Road to Reduction' campaign drew 9.37 million views in just one month, signaling the brand's growing visibility and leadership in the epilepsy treatment market.